Key result
The renin-angiotensin system exhibits complex immunomodulatory properties across oncology, intensive care, and solid organ transplantation, warranting further research into targeted RAS treatments.
Why the study?
Beyond blood pressure homeostasis, the renin-angiotensin system exerts effects on proliferation, fibrosis, and inflammation, prompting an evaluation of its immunomodulatory properties across distinct clinical fields.
This review highlights the complex direct and indirect interactions of the renin-angiotensin system with immunomodulatory pathways beyond blood pressure homeostasis.
Answers are grounded in this paper and cite their sources.
Should not yet change RAS inhibitor use; hypothesis-generating for targeted immunomodulation in oncology and transplantation.
The renin-angiotensin system (RAS) has long been described in the field of cardiovascular physiology as the main player in blood pressure homeostasis. However, other effects have since been described, and include proliferation, fibrosis, and inflammation. To illustrate the immunomodulatory properties of the RAS, we chose three distinct fields in which RAS may play a critical role and be the subject of specific treatments. In oncology, RAS hyperactivation has been associated with tumor migration, survival, cell proliferation, and angiogenesis; preliminary data showed promise of the benefit of RAS blockers in patients treated for certain types of cancer. In intensive care medicine, vasoplegic shock has been associated with severe macro- and microcirculatory imbalance. A relative insufficiency in angiotensin II (AngII) was associated to lethal outcomes and synthetic AngII has been suggested as a specific treatment in these cases. Finally, in solid organ transplantation, both AngI and AngII have been associated with increased rejection events, with a regional specificity in the RAS activity. These elements emphasize the complexity of the direct and indirect interactions of RAS with immunomodulatory pathways and warrant further research in the field.
No takes yet. Share an insight, caveat, or question.
Laghlam et al. (2021) conducted a review in Immunomodulation in oncology, intensive care, and solid organ transplantation. Renin-angiotensin system modulators was evaluated. The renin-angiotensin system exhibits complex immunomodulatory properties across oncology, intensive care, and solid organ transplantation, warranting further research into targeted RAS treatments.
Synapse has enriched 10 related papers. Consider them for comparative context: